(Q44217548)

English

Combined lamivudine and hepatitis B immunoglobulin for the prevention of hepatitis B recurrence after liver transplantation: long-term results

scientific article published in August 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Combined lamivudine and hepatitis B immunoglobulin for the prevention of hepatitis B recurrence after liver transplantation: long-term results (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

liver transplantation

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Jérôme Dumortier

1

object named as

Jérôme Dumortier

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Olivier Boillot

5

object named as

Olivier Boillot

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

author name string

Philippe Chevallier

2

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Jean-Yves Scoazec

3

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Françoise Berger

4

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

language of work or name

0 references

publication date

1 August 2003

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

American Journal of Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

999-1002

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Prevention of and treatment for hepatitis B virus infection after liver transplantation in the nucleoside analogues era.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00191.X

21 January 2018

Lamivudine treatment is beneficial in patients with severely decompensated cirrhosis and actively replicating hepatitis B infection awaiting liver transplantation: a comparative study using a matched, untreated cohort

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00191.X

21 January 2018

High pre-treatment serum hepatitis B virus titre predicts failure of lamivudine prophylaxis and graft re-infection after liver transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00191.X

21 January 2018

Outcome of lamivudine resistant hepatitis B virus infection in the liver transplant recipient

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00191.X

21 January 2018

A multicenter United States-Canadian trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00191.X

21 January 2018

Prevention of hepatitis B virus recurrence after liver transplantation in cirrhotic patients treated with lamivudine and passive immunoprophylaxis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00191.X

21 January 2018

Lamivudine and low-dose hepatitis B immune globulin for prophylaxis of hepatitis B reinfection after liver transplantation possible role of mutations in the YMDD motif prior to transplantation as a risk factor for reinfection

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00191.X

21 January 2018

Lamivudine after hepatitis B immune globulin is effective in preventing hepatitis B recurrence after liver transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00191.X

21 January 2018

Randomized trial of lamivudine versus hepatitis B immunoglobulin for long-term prophylaxis of hepatitis B recurrence after liver transplantation.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00191.X

21 January 2018

Conversion from intravenous to intramuscular hepatitis B immune globulin in combination with lamivudine is safe and cost-effective in patients receiving long-term prophylaxis to prevent hepatitis B recurrence after liver transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00191.X

21 January 2018

Passive immunoprophylaxis after liver transplantation in HBsAg-positive patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00191.X

21 January 2018

Liver transplantation in European patients with the hepatitis B surface antigen

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00191.X

21 January 2018

Efficacy of lamivudine in chronic hepatitis B patients with active viral replication and decompensated cirrhosis undergoing liver transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00191.X

21 January 2018

Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00191.X

21 January 2018

Hepatitis B virus reinfection after orthotopic liver transplantation. Serological and clinical implications

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00191.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Liver transplantation in HBs antigen (HBsAg) carriers. Prevention of hepatitis B virus (HBV) recurrence by passive immunization

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00191.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis B immune globulin to prevent hepatitis B virus graft reinfection following liver transplantation: a concise review

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00191.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Prophylaxis and treatment of recurrent hepatitis B after liver transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00191.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Intramuscular hepatitis B immune globulin combined with lamivudine for prophylaxis against hepatitis B recurrence after liver transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00191.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetic alterations in the S gene of hepatitis B virus in patients with acute hepatitis B, chronic hepatitis B and hepatitis B liver cirrhosis before and after liver transplantation.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00191.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00191.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00191.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Lamivudine therapy in patients undergoing liver transplantation for hepatitis B virus precore mutant-associated infection: high resistance rates in treatment of recurrence but universal prevention if used as prophylaxis with very low dose [...]

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00191.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Liver transplantation for chronic hepatitis B infection with the use of combination lamivudine and low-dose hepatitis B immune globulin

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00191.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis B immunoglobulin discontinuation followed by hepatitis B virus vaccination: A new strategy in the prophylaxis of hepatitis B virus recurrence after liver transplantation.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2003.00191.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1034/J.1600-6143.2003.00191.X

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44217548&oldid=2108641519"